Balamurugan Tangiisuran, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pharmacists | 3 | 2020 | 260 | 1.240 |
Why?
|
Malaysia | 15 | 2022 | 107 | 1.110 |
Why?
|
Community Pharmacy Services | 1 | 2020 | 52 | 0.690 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 4016 | 0.680 |
Why?
|
Household Products | 1 | 2018 | 27 | 0.640 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 118 | 0.640 |
Why?
|
Accidents | 1 | 2018 | 165 | 0.590 |
Why?
|
Poisoning | 1 | 2018 | 252 | 0.570 |
Why?
|
Nursing Staff | 1 | 2017 | 113 | 0.530 |
Why?
|
Medication Therapy Management | 1 | 2017 | 130 | 0.520 |
Why?
|
Pesticides | 1 | 2018 | 296 | 0.520 |
Why?
|
Intention | 1 | 2018 | 347 | 0.510 |
Why?
|
Inappropriate Prescribing | 2 | 2014 | 211 | 0.460 |
Why?
|
Long-Term Care | 1 | 2017 | 633 | 0.420 |
Why?
|
Medication Adherence | 3 | 2019 | 2176 | 0.410 |
Why?
|
Hypoglycemia | 1 | 2019 | 883 | 0.390 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1010 | 0.390 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7407 | 0.380 |
Why?
|
Delphi Technique | 1 | 2015 | 846 | 0.370 |
Why?
|
Hyperglycemia | 1 | 2019 | 1376 | 0.360 |
Why?
|
Poisons | 2 | 2022 | 38 | 0.350 |
Why?
|
Nursing Homes | 2 | 2014 | 1082 | 0.320 |
Why?
|
Attitude of Health Personnel | 4 | 2017 | 3889 | 0.300 |
Why?
|
Guideline Adherence | 2 | 2015 | 2220 | 0.290 |
Why?
|
Nigeria | 2 | 2020 | 770 | 0.270 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3085 | 0.270 |
Why?
|
Hospitalization | 5 | 2016 | 10721 | 0.270 |
Why?
|
Physicians | 2 | 2021 | 4591 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.250 |
Why?
|
Caregivers | 1 | 2017 | 2238 | 0.240 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.230 |
Why?
|
Cross-Sectional Studies | 9 | 2020 | 26127 | 0.210 |
Why?
|
Models, Theoretical | 1 | 2014 | 3575 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12148 | 0.190 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7879 | 0.180 |
Why?
|
Drug Prescriptions | 2 | 2010 | 1670 | 0.180 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2017 | 494 | 0.180 |
Why?
|
Nicotinic Agonists | 1 | 2022 | 265 | 0.170 |
Why?
|
Polypharmacy | 1 | 2021 | 306 | 0.160 |
Why?
|
Legislation, Drug | 1 | 2020 | 214 | 0.150 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 625 | 0.140 |
Why?
|
Drugs, Chinese Herbal | 1 | 2019 | 144 | 0.140 |
Why?
|
Algorithms | 2 | 2017 | 14032 | 0.120 |
Why?
|
Homes for the Aged | 1 | 2017 | 272 | 0.120 |
Why?
|
Perception | 2 | 2019 | 1197 | 0.120 |
Why?
|
Antidepressive Agents | 2 | 2017 | 2897 | 0.120 |
Why?
|
Sex Distribution | 1 | 2018 | 2281 | 0.110 |
Why?
|
Quality of Life | 2 | 2019 | 13367 | 0.110 |
Why?
|
Aged | 13 | 2021 | 169310 | 0.110 |
Why?
|
Male | 18 | 2020 | 360842 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
Databases as Topic | 1 | 2014 | 473 | 0.100 |
Why?
|
Nutritional Support | 1 | 2014 | 173 | 0.100 |
Why?
|
Inpatients | 3 | 2017 | 2548 | 0.100 |
Why?
|
Humans | 26 | 2022 | 761572 | 0.100 |
Why?
|
Female | 18 | 2020 | 392686 | 0.100 |
Why?
|
Geriatric Assessment | 2 | 2017 | 1410 | 0.090 |
Why?
|
Prevalence | 3 | 2019 | 15732 | 0.090 |
Why?
|
General Practitioners | 1 | 2012 | 101 | 0.090 |
Why?
|
Qualitative Research | 1 | 2021 | 3023 | 0.090 |
Why?
|
Professional Competence | 1 | 2014 | 431 | 0.090 |
Why?
|
Heart Failure | 1 | 2015 | 11670 | 0.090 |
Why?
|
Nutrition Assessment | 1 | 2014 | 728 | 0.090 |
Why?
|
Medication Reconciliation | 1 | 2012 | 153 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2017 | 58986 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
Depressive Disorder, Major | 2 | 2017 | 4761 | 0.080 |
Why?
|
Hospitals, University | 1 | 2010 | 564 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2022 | 80646 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2024 | 0.070 |
Why?
|
Europe | 1 | 2014 | 3422 | 0.070 |
Why?
|
Stroke | 2 | 2020 | 9758 | 0.070 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1156 | 0.070 |
Why?
|
Malnutrition | 1 | 2014 | 645 | 0.070 |
Why?
|
Prospective Studies | 5 | 2020 | 54426 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3049 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8633 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1188 | 0.070 |
Why?
|
Risk Factors | 8 | 2020 | 74213 | 0.070 |
Why?
|
Middle Aged | 9 | 2020 | 220920 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39107 | 0.060 |
Why?
|
Continuity of Patient Care | 1 | 2012 | 1069 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4686 | 0.060 |
Why?
|
Comorbidity | 2 | 2019 | 10508 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21355 | 0.060 |
Why?
|
Patient Discharge | 2 | 2016 | 3443 | 0.050 |
Why?
|
Recurrence | 3 | 2020 | 8466 | 0.050 |
Why?
|
Risk Assessment | 4 | 2020 | 23996 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12059 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3204 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4573 | 0.050 |
Why?
|
Adult | 7 | 2022 | 221203 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7054 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 42230 | 0.040 |
Why?
|
Bupropion | 1 | 2022 | 304 | 0.040 |
Why?
|
Quinoxalines | 1 | 2022 | 296 | 0.040 |
Why?
|
Benzazepines | 1 | 2022 | 310 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20099 | 0.040 |
Why?
|
Epirubicin | 1 | 2019 | 81 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29629 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11742 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12947 | 0.040 |
Why?
|
Hypertension | 2 | 2020 | 8540 | 0.040 |
Why?
|
Depression | 1 | 2016 | 8124 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2019 | 486 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7391 | 0.030 |
Why?
|
Fluorouracil | 1 | 2019 | 1642 | 0.030 |
Why?
|
Registries | 2 | 2020 | 8224 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1089 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2220 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2522 | 0.030 |
Why?
|
Personnel, Hospital | 1 | 2014 | 285 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21017 | 0.020 |
Why?
|
Child | 1 | 2020 | 80156 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 244 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8711 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2113 | 0.020 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39970 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3917 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4077 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2022 | 64684 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10553 | 0.020 |
Why?
|
Nutritional Status | 1 | 2014 | 1615 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9053 | 0.020 |
Why?
|
Medication Errors | 1 | 2010 | 783 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11121 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14607 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12954 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3725 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1792 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26198 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3271 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14666 | 0.010 |
Why?
|
Hospitals | 1 | 2014 | 3882 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36192 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41493 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13510 | 0.010 |
Why?
|
Mass Screening | 1 | 2014 | 5428 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88324 | 0.010 |
Why?
|